Single Rising Dose Study (Intravenous Infusion and Subcutaneous Injection) of BI 655064 in Healthy Male Volunteers

NCT01510782 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo to BI 655064
DRUG: Placebo to BI 655064
DRUG: BI 655064
DRUG: BI 655064

Sponsor

Boehringer Ingelheim